scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Deepak Shukla | |
Salvador Nares | |||
Afsar R Naqvi | |||
Alexandra Seal | |||
Jennifer Shango | |||
P2860 | cites work | Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells | Q24555724 |
Update on human herpesvirus 6 biology, clinical features, and therapy | Q24557543 | ||
Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines | Q24594085 | ||
Small RNA deep sequencing identifies microRNAs and other small noncoding RNAs from human herpesvirus 6B | Q24604164 | ||
MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory signaling | Q24611853 | ||
Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry | Q24651228 | ||
A viral microRNA functions as an orthologue of cellular miR-155 | Q24652947 | ||
Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed | Q25257225 | ||
The Role of microRNAs in the Pathogenesis of Herpesvirus Infection | Q26748350 | ||
Diagnostic Value of microRNA for Alzheimer's Disease: A Systematic Review and Meta-Analysis | Q26768181 | ||
MicroRNA regulation of lymphocyte tolerance and autoimmunity | Q26852975 | ||
Clinical impact of primary infection with roseoloviruses | Q27025365 | ||
The role of RNAi and microRNAs in animal virus replication and antiviral immunity | Q27490179 | ||
Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA | Q27861124 | ||
Regulation of microRNA biogenesis | Q28243976 | ||
Identification of virus-encoded microRNAs | Q28259309 | ||
An ecological and evolutionary perspective on human-microbe mutualism and disease | Q29614265 | ||
A cellular microRNA mediates antiviral defense in human cells | Q29615828 | ||
Identification of microRNAs of the herpesvirus family | Q29618671 | ||
NF-kappaB at the crossroads of life and death | Q29619302 | ||
The many challenges of facial herpes simplex virus infection | Q30978472 | ||
Oral Kaposi's sarcoma: a review and update | Q38107277 | ||
How do viruses avoid inhibition by endogenous cellular microRNAs? | Q38163528 | ||
MicroRNAs in cancer: biomarkers, functions and therapy | Q38229952 | ||
Role of microRNAs in herpesvirus latency and persistence. | Q38269181 | ||
Epstein-Barr virus: dermatologic associations and implications: part I. Mucocutaneous manifestations of Epstein-Barr virus and nonmalignant disorders | Q38286610 | ||
Viruses in pulp and periapical inflammation: a review. | Q38386364 | ||
Human herpesvirus-6 (HHV-6) DNA and virus-encoded antigen in oral lesions | Q38473260 | ||
Role of miRNA in cancer diagnosis, prognosis, therapy and regulation of its expression by Epstein-Barr virus and human papillomaviruses: With special reference to oral cancer. | Q38532975 | ||
Periodontal herpesviruses: prevalence, pathogenicity, systemic risk | Q38562419 | ||
Herpesviruses shape tumour microenvironment through exosomal transfer of viral microRNAs | Q38610039 | ||
Periodontitis: facts, fallacies and the future | Q38649509 | ||
Contribution of MicroRNAs to autoimmune diseases | Q38760874 | ||
EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN. | Q38944897 | ||
Activation of CCR2+ human proinflammatory monocytes by human herpesvirus-6B chemokine N-terminal peptide. | Q38947933 | ||
Epstein-Barr virus is associated with periodontal diseases: A meta-analysis based on 21 case-control studies | Q38971859 | ||
Viral MicroRNAs Identified in Human Dental Pulp | Q39112606 | ||
Selective degradation of host MicroRNAs by an intergenic HCMV noncoding RNA accelerates virus production | Q39139523 | ||
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases | Q39139786 | ||
Impact of microRNA dynamics on cancer hallmarks: An oral cancer scenario | Q39202825 | ||
Subgingival Epstein-Barr and Cytomegalovirus Occurrence in Pregnancy Gingivitis | Q61885419 | ||
RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons | Q68986775 | ||
Diagnosis of cytomegalovirus infection | Q69842136 | ||
Brief report: severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult | Q70461195 | ||
Quantitative analysis of association between herpesviruses and bacterial pathogens in periodontitis | Q80215291 | ||
How do microRNAs regulate gene expression? | Q82671947 | ||
Oral ulcers in HIV-positive Peruvian patients: an immunohistochemical and in situ hybridization study | Q83293643 | ||
MiR-101 regulates HSV-1 replication by targeting ATP5B | Q83364749 | ||
Latency and reactivation of human cytomegalovirus | Q83946800 | ||
Association of human herpesvirus 6 subtypes with symptomatic apical periodontitis | Q84046183 | ||
Physiological and pathological roles for microRNAs in the immune system | Q37680666 | ||
Viral RNA silencing suppressors (RSS): Novel strategy of viruses to ablate the host RNA interference (RNAi) defense system | Q37800635 | ||
Kaposi sarcoma: review and medical management update | Q38017050 | ||
MicroRNAs function as tumor suppressors or oncogenes: aberrant expression of microRNAs in head and neck squamous cell carcinoma | Q38029447 | ||
MicroRNAs as mediators of viral evasion of the immune system | Q38082296 | ||
Viruses: are they really culprits for periodontal disease? A critical review | Q38085262 | ||
Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA | Q33625562 | ||
MicroRNAs: new insights into the pathogenesis of endodontic periapical disease | Q33640951 | ||
Cytomegalovirus miRNAs target secretory pathway genes to facilitate formation of the virion assembly compartment and reduce cytokine secretion. | Q33644138 | ||
Distinct expression profile of HCMV encoded miRNAs in plasma from oral lichen planus patients. | Q33776574 | ||
Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2. | Q33826615 | ||
A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus | Q33838266 | ||
Integrated microRNA-mRNA-analysis of human monocyte derived macrophages upon Mycobacterium avium subsp. hominissuis infection | Q33918122 | ||
Herpes simplex virus infections | Q33948597 | ||
MiRNA-181a regulates Toll-like receptor agonist-induced inflammatory response in human fibroblasts | Q33953542 | ||
Identification and characterization of human cytomegalovirus-encoded microRNAs | Q33987509 | ||
A neuron-specific host microRNA targets herpes simplex virus-1 ICP0 expression and promotes latency | Q34081540 | ||
Kaposi's sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosis | Q34102689 | ||
miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. | Q34112056 | ||
Cellular MicroRNAs 200b and 429 Regulate the Epstein-Barr Virus Switch between Latency and Lytic Replication | Q34120915 | ||
MicroRNA modulation in obesity and periodontitis | Q34229300 | ||
Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and dicer | Q34261764 | ||
Differential expression of microRNAs in normal and inflamed human pulps | Q34275618 | ||
Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression | Q34291063 | ||
Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry | Q34344174 | ||
A population-based study of primary human herpesvirus 6 infection | Q34397270 | ||
Host-virus interaction: a new role for microRNAs | Q34573002 | ||
Cellular microRNAs 498 and 320d regulate herpes simplex virus 1 induction of Kaposi's sarcoma-associated herpesvirus lytic replication by targeting RTA. | Q34589617 | ||
MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs | Q34593731 | ||
Detection of circulating hcmv-miR-UL112-3p in patients with glioblastoma, rheumatoid arthritis, diabetes mellitus and healthy controls | Q34612095 | ||
MiR-23a facilitates the replication of HSV-1 through the suppression of interferon regulatory factor 1. | Q34612130 | ||
MiR-181a regulates inflammation responses in monocytes and macrophages | Q34629860 | ||
Virus-encoded microRNAs | Q34640166 | ||
Prediction and identification of herpes simplex virus 1-encoded microRNAs | Q34648394 | ||
MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases | Q34772318 | ||
The role of viruses in oral disease | Q34886959 | ||
The HIV-1 Nef protein binds argonaute-2 and functions as a viral suppressor of RNA interference | Q34984704 | ||
Human cytomegalovirus and Epstein-Barr virus in etiopathogenesis of apical periodontitis: a systematic review | Q35065773 | ||
A human herpesvirus 6A-encoded microRNA: role in viral lytic replication | Q35076734 | ||
Herpes simplex virus 2 microRNA miR-H6 is a novel latency-associated transcript-associated microRNA, but reduction of its expression does not influence the establishment of viral latency or the recurrence phenotype | Q35076893 | ||
Herpes simplex type-1 virus infection. | Q35177275 | ||
Herpesvirus microRNAs: phenotypes and functions | Q35209821 | ||
Laboratory and clinical aspects of human herpesvirus 6 infections | Q35482603 | ||
Role of viruses in oral squamous cell carcinoma | Q35569336 | ||
Fusing structure and function: a structural view of the herpesvirus entry machinery | Q35622700 | ||
Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma | Q35634894 | ||
High-resolution profiling and analysis of viral and host small RNAs during human cytomegalovirus infection | Q35666044 | ||
Regulation of miR-24, miR-30b, and miR-142-3p during macrophage and dendritic cell differentiation potentiates innate immunity | Q35850029 | ||
Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma | Q35865016 | ||
Association between Herpesviruses and Chronic Periodontitis: A Meta-Analysis Based on Case-Control Studies | Q35868438 | ||
Divergent target recognition by coexpressed 5'-isomiRs of miR-142-3p and selective viral mimicry | Q35952782 | ||
MicroRNA-181b regulates NF-κB-mediated vascular inflammation | Q36005391 | ||
The microRNA Transcriptome of Human Cytomegalovirus (HCMV) | Q36041191 | ||
Herpesviruses in periodontal diseases | Q36107779 | ||
Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus | Q36131519 | ||
Comparison of microRNA profiles of human periodontal diseased and healthy gingival tissues | Q36313842 | ||
Epstein-Barr virus in oral diseases | Q36530296 | ||
Differential expression of miRNAs in the serum of patients with high-risk oral lesions | Q36530712 | ||
MicroRNA Regulation of Atherosclerosis | Q36602813 | ||
miR-H28 and miR-H29 expressed late in productive infection are exported and restrict HSV-1 replication and spread in recipient cells | Q36607520 | ||
Herpes simplex virus 1 microRNAs expressed abundantly during latent infection are not essential for latency in mouse trigeminal ganglia | Q36610821 | ||
Molecular evolution of herpesviruses: genomic and protein sequence comparisons | Q36630244 | ||
An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor | Q36825232 | ||
Mutational inactivation of herpes simplex virus 1 microRNAs identifies viral mRNA targets and reveals phenotypic effects in culture | Q36911631 | ||
Regulation of viral oncogenesis by microRNAs | Q36997713 | ||
KSHV infection and the pathogenesis of Kaposi's sarcoma | Q37014777 | ||
Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features | Q37058139 | ||
Micromanagement of the immune system by microRNAs | Q37060274 | ||
The fascinating world of RNA interference | Q37073505 | ||
MicroRNAs: new regulators of immune cell development and function | Q37223449 | ||
miR-24, miR-30b and miR-142-3p interfere with antigen processing and presentation by primary macrophages and dendritic cells | Q37244315 | ||
Novel less-abundant viral microRNAs encoded by herpes simplex virus 2 latency-associated transcript and their roles in regulating ICP34.5 and ICP0 mRNAs. | Q37329754 | ||
Two small RNAs encoded within the first 1.5 kilobases of the herpes simplex virus type 1 latency-associated transcript can inhibit productive infection and cooperate to inhibit apoptosis | Q37333965 | ||
microRNAs: Emerging players in oral cancers and inflammatory disorders | Q39274997 | ||
Herpesvirus microRNAs for use in gene therapy immune-evasion strategies | Q39293464 | ||
Overexpression of Epstein-Barr virus-encoded microRNA-BART7 in undifferentiated nasopharyngeal carcinoma | Q39306381 | ||
Periodontopathogen and Epstein-Barr virus-associated periapical periodontitis may be the source of retrograde infectious peri-implantitis | Q39418680 | ||
Epidemiology and transmission of cytomegalovirus | Q39496031 | ||
The metabolic activator FOXO1 binds hepatitis B virus DNA and activates its transcription. | Q39881340 | ||
MicroRNA: Dynamic Regulators of Macrophage Polarization and Plasticity | Q40044861 | ||
Herpes Simplex 1 and Periopathogen Role in Peri-implantitis | Q40198750 | ||
Analysis of circulating human and viral microRNAs in patients with congenital cytomegalovirus infection. | Q40522964 | ||
Prevalence of herpesviruses in gingivitis and chronic periodontitis: relationship to clinical parameters and effect of treatment | Q40562490 | ||
Hcmv-miR-UL22A-5p: A Biomarker in Transplantation With Broad Impact on Host Gene Expression and Potential Immunological Implications | Q41362923 | ||
Expression of herpes simplex virus 1 microRNAs in cell culture models of quiescent and latent infection | Q41908903 | ||
The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma | Q41921755 | ||
Epstein-Barr virus associated peri-implantitis: a split-mouth study. | Q42220211 | ||
Mycobacterium tuberculosis controls microRNA-99b (miR-99b) expression in infected murine dendritic cells to modulate host immunity | Q42225424 | ||
MicroRNAs and their target genes in gingival tissues. | Q42326429 | ||
Detection of human cytomegalovirus and Epstein-Barr Virus in symptomatic and asymptomatic apical periodontitis lesions by real-time PCR. | Q42957155 | ||
miR-24, miR-30b, and miR-142-3p regulate phagocytosis in myeloid inflammatory cells. | Q43142164 | ||
Herpesviruses in asymptomatic apical periodontitis lesions: an immunohistochemical approach | Q43432052 | ||
Is herpes simplex virus associated with pulp/periapical inflammation? | Q43520696 | ||
Human cytomegalovirus-associated oral and maxillo-facial disease | Q43674920 | ||
Human herpesvirus 7, Epstein-Barr virus and human cytomegalovirus in periodontal tissues of periodontally diseased and healthy subjects | Q44324779 | ||
Are dental diseases examples of ecological catastrophes? | Q44353925 | ||
Herpesviral-bacterial coinfection in periapical pathosis | Q44426002 | ||
Significance of human cytomegalovirus and Epstein-Barr virus in inducing cytokine expression in periapical lesions | Q44730041 | ||
Comparative analysis of presence of Cytomegalovirus (CMV) and Epsteinbarr virus -1 (EBV-1) in cases of chronic periodontitis and aggressive periodontitis with controls | Q45353394 | ||
Correlation between different genotypes of human cytomegalovirus and Epstein-Barr virus and peri-implant tissue status | Q45361396 | ||
Prevalence and activity of Epstein-Barr virus and human cytomegalovirus in symptomatic and asymptomatic apical periodontitis lesions. | Q45373558 | ||
Detection of presence or absence of herpes simplex virus, Epstein Barr virus and human cytomegalovirus in infected pulp using a polymerase chain reaction | Q45384402 | ||
Herpesviruses in endodontic pathoses: association of Epstein-Barr virus with irreversible pulpitis and apical periodontitis | Q45387947 | ||
Patient with severe periodontitis and subgingival Epstein-Barr virus treated with antiviral therapy | Q45396866 | ||
Studies on the possible presence of a virus in subacute and choronic periapical granulomas | Q45716120 | ||
Cytomegalovirus and Epstein-Barr virus active infection in periapical lesions of teeth with intact crowns | Q45723407 | ||
Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. | Q45733066 | ||
Detection of human viruses in periodontal pockets using polymerase chain reaction | Q46110571 | ||
The oral microbiome - an update for oral healthcare professionals. | Q46458785 | ||
Herpesviruses in periodontal pocket and gingival tissue specimens | Q46734914 | ||
EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma | Q47259217 | ||
Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells | Q47978435 | ||
Herpesviridae. Definition, provisional nomenclature, and taxonomy. The Herpesvirus Study Group, the International Committee on Taxonomy of Viruses. | Q50717495 | ||
HHV-6 infection of tonsils and adenoids in children with hypertrophy and upper airway recurrent infections. | Q51602539 | ||
MicroRNA target Fc receptors to regulate Ab-dependent Ag uptake in primary macrophages and dendritic cells. | Q51622640 | ||
Viral miRNAs Alter Host Cell miRNA Profiles and Modulate Innate Immune Responses. | Q51737478 | ||
Immunological methods for the detection of human cytomegalovirus. | Q51978901 | ||
Herpesvirus-encoded microRNAs detected in human gingiva alter host cell transcriptome and regulate viral infection. | Q52351840 | ||
Comparison of inflammatory microRNA expression in healthy and periodontitis tissues. | Q54336293 | ||
Viral-bacterial associations in acute apical abscesses. | Q54376960 | ||
Identification of herpesviruses types 1 to 8 and human papillomavirus in acute apical abscesses. | Q54398085 | ||
In silico prediction of cellular gene targets of herpesvirus encoded microRNAs. | Q55375932 | ||
Subgingival Human Cytomegalovirus Correlates With Increased Clinical Periodontal Parameters and Bacterial Coinfection in Periodontitis | Q59345990 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microRNA | Q310899 |
virus | Q808 | ||
host microbial interaction | Q68260314 | ||
P304 | page(s) | 2099 | |
P577 | publication date | 2018-01-01 | |
2018-09-27 | |||
P1433 | published in | Frontiers in Immunology | Q27723748 |
P1476 | title | Herpesviruses and MicroRNAs: New Pathogenesis Factors in Oral Infection and Disease? | |
P478 | volume | 9 |
Q59349460 | Dysregulation of human miRNAs and increased prevalence of HHV miRNAs in obese periodontitis subjects |
Q96811102 | Extracellular Vesicles in Viral Infections of the Nervous System |
Q92129893 | Identification and Characterization of MiRNAs in Coccomyxa subellipsoidea C-169 |
Q90207554 | Polymicrobial periodontal disease triggers a wide radius of effect and unique virome |
Q92987705 | The Role of Extracellular Vesicles in Viral Infection and Transmission |
Search more.